ACTN3 R577X polymorphism and Israeli top-level athletes
- PMID: 19544227
- DOI: 10.1055/s-0029-1220731
ACTN3 R577X polymorphism and Israeli top-level athletes
Erratum in
- Int J Sports Med. 2009 Nov;30(11):839
Abstract
A common genetic variation in the alpha-actinin-3 ( ACTN3) gene causes a replacement of an arginine (R) with a premature stop codon (X) at amino-acid 577 (rs1815739). While the R allele has been found to be associated with power-oriented performance, the XX genotype may be linked with endurance ability. To test this hypothesis, we studied the distribution of ACTN3 genotypes in 155 Israeli athletes (age=35.9+12.2 years) classified by sport (endurance runners and sprinters) and in 240 sedentary individuals. The sprinters' allele frequencies (AF: R/X=0.7/0.3) and 577RR genotype distribution percentage (GD: RR=52%) differed markedly from those of the endurance athletes (AF: R/X=0.53/0.47, p=0.000007; GD: RR=18%, p=0.00009) and the control group (AF: R/X=0.55/0.45, p=0.0002; GD: RR=27.3%, p=0.000003). A comparison between the top-level and national-level sprinters revealed that the R allele occurs more often in the top-level sprinters. A significantly higher proportion of the XX genotype was observed in endurance athletes (34%) compared with controls (18%, p=0.02) and sprinters (13%, p=0.002). However, top-level and national level endurance athletes had similar allele and genotype frequencies. We conclude that the ACTN3 R allele is associated with top-level sprint performance and the X allele and XX genotypes may not be critical but rather additive to endurance performance.
Georg Thieme Verlag KG Stuttgart.
Similar articles
-
Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance?Metabolism. 2010 Jun;59(6):861-5. doi: 10.1016/j.metabol.2009.10.003. Epub 2009 Dec 16. Metabolism. 2010. PMID: 20005538
-
ACTN3 genotype in professional endurance cyclists.Int J Sports Med. 2006 Nov;27(11):880-4. doi: 10.1055/s-2006-923862. Epub 2006 Apr 11. Int J Sports Med. 2006. PMID: 16612741
-
The ACE deletion allele is associated with Israeli elite endurance athletes.Exp Physiol. 2007 Sep;92(5):881-6. doi: 10.1113/expphysiol.2007.038711. Epub 2007 Jul 13. Exp Physiol. 2007. PMID: 17631516
-
A Systematic Review and Meta-analysis of the Association Between ACTN3 R577X Genotypes and Performance in Endurance Versus Power Athletes and Non-athletes.Sports Med Open. 2024 Apr 12;10(1):37. doi: 10.1186/s40798-024-00711-x. Sports Med Open. 2024. PMID: 38609671 Free PMC article.
-
The Effect of Heterozygosity for the ACTN3 Null Allele on Human Muscle Performance.Med Sci Sports Exerc. 2016 Mar;48(3):509-20. doi: 10.1249/MSS.0000000000000784. Med Sci Sports Exerc. 2016. PMID: 26429734 Review.
Cited by
-
Association of ACTN3 R577X Polymorphism with Elite Basketball Player Status and Training Responses.Genes (Basel). 2023 May 29;14(6):1190. doi: 10.3390/genes14061190. Genes (Basel). 2023. PMID: 37372374 Free PMC article.
-
Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy.Nat Commun. 2017 Jan 31;8:14143. doi: 10.1038/ncomms14143. Nat Commun. 2017. PMID: 28139640 Free PMC article.
-
ACTN3 R577X Polymorphism and Neuromuscular Response to Resistance Training.J Sports Sci Med. 2011 Jun 1;10(2):393-9. eCollection 2011. J Sports Sci Med. 2011. PMID: 24149888 Free PMC article.
-
Genes and elite athletes: a roadmap for future research.J Physiol. 2011 Jul 1;589(Pt 13):3063-70. doi: 10.1113/jphysiol.2011.207035. Epub 2011 May 3. J Physiol. 2011. PMID: 21540342 Free PMC article. Review.
-
ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure.BMC Cardiovasc Disord. 2014 Jul 24;14:90. doi: 10.1186/1471-2261-14-90. BMC Cardiovasc Disord. 2014. PMID: 25059829 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources